Vice President Europe and Director IBM Research – Zurich
Dr. Alessandro Curioni was named Vice President, Europe and Director of the IBM Research – Zurich Lab in April 2015. In addition, since November 2015 he is leading the research activities for the newly formed Watson IoT unit. Dr. Curioni is an internationally renowned leader in the area of high-performance computing and computational science, where his innovative thinking and seminal contributions have helped solve some of the most complex scientific and technological problems in several industries including healthcare, consumer goods and electronics. In 2014, Dr. Curioni was promoted to the rank of IBM Fellow, the corporation's highest technical recognition. In 2013, he was a member of the winning team recognized with the prestigious Gordon Bell Prize by setting a new record of 14 Petaflops in simulation performance, recognition that he received for the second time also in 2015. Moreover, Dr. Curioni and his colleagues received the PRACE Award in 2012 and the US National Medal for Technology and Innovation in 2008 for the IBM Blue Gene family of high-performance computers. Dr. Curioni started at IBM Research – Zurich as a PhD student in 1993 before officially joining as a research staff member in 1998. Prior to becoming Vice President and Director, he was head of the former Cognitive Computing and Computational Sciences department. Dr. Curioni received his undergraduate degree in Theoretical Chemistry and his Ph.D. from Scuola Normale Superiore, Pisa, Italy.
Director Graphene Group
Program manager SIO Grafen & Innovation team Graphene Flagship. Convinced that collaborations is key to get graphene from the lab to the market.
James Franck Institute and the Institute for Molecular Engineering
Professor of chemistry
We build modern integrated circuits using atomically thin materials by combining chemical and physical approaches.
Dr. Antonio Abate
Helmholtz-Zentrum Berlin für Materialien und Energie
My main research interests are in optoelectronic properties of self assembling organic materials for applications in photovoltaic devices.
IBM Zurich Research Laboratory
Dr. Delamarche is currently leading activities on Precision Diagnostics at IBM Research - Zurich with the goal of developing expertise in microtechnology, surface chemistry and biochemistry for solving important problems in biology and medicine. His current projects deal with investigating intercellular pathways relevant to neurodegenerative diseases, developing new techniques for tissue section analysis, and microfluidics for point-of-care testing diagnostics. This involves the fast and sensitive detection of multiple markers for various diseases, the advanced staining of tissue sections for pathology, and cell-to-cell interactions within the context of Parkinson's and Alzheimer's diseases. His expertise covers self-assembly, soft lithography, miniaturized biological assays based on microfluidics, and nanotechnology in general. Dr. Delamarche sometimes acts as a research expert for IBM-internal task forces, consulting engagements, and frequently as an expert for major governmental research programs. He is also a Lecturer at ETH Zurich in the Department of Health Science and Technologies. Dr. Delamarche received a degree in Chemistry in 1992 from the University Paul Sabatier of Toulouse in France. He received a Ph.D. in Biochemistry in 1995 from the University of Zurich for work done at IBM Research - Zurich, where he became a Research Staff Member in 1998. Dr. Delamarche has co-authored 120+ publications, several book chapters, reviews and over 70 patents. Dr. Delamarche is one of the most cited scientists in the fields of self-assembly and microfluidics. He has received 15 awards from IBM for his work and inventions, was named an IBM "Master Inventor" in 2003, and received the Werner prize of the Swiss Chemical Society in 2006.
Alfredo De la Escosura Muniz
Institut Catala de Nanociència i Nanotecnologia (ICN2)
Senior Postdoctoral Researcher
Dr. De la Escosura-Muñiz received his PhD in Chemistry in 2006 from the University of Oviedo (Spain). His post-doctoral period (2007-2010) was granted by a Juan de la Cierva Research Fellow at the Institute of Nanoscience of Aragon (Spain) in collaboration with the Catalan Institute of Nanotechnology (Spain), including a stay at the Chalmers University of Technology (Sweden). From 2011 to 2017 he has been working as Senior Researcher at the Catalan Institute of Nanoscience and Nanotechnology (Spain). Dr. De la Escosura-Muñiz has broad experience in biosensing systems based on nanoparticles and nanochannels for point-of-care diagnostic applications. He has been involved in more than 20 national and international projects and is coauthor of over 55 peer review scientific publications and 3 patents.
Low-temperature optical and spin spectroscopy of rare-earth-ion-doped materials Coherent light-atom interactions in gaseous and solid state materials Quantum optics Quantum storage devices for single photons Quantum communication/Quantum repeaters Phys. Rev. B 94, 155116 (2016) High-Precision Measurement of the Dzyaloshinsky-Moriya Interaction between Two Rare-Earth Ions in a Solid, Phys. Rev. Lett. 117, 037203 (2016) Noise in optical quantum memories based on dynamical decoupling of spin states, Journal of Modern Optics 0, 1-13 (2016) Demonstration of Light-Matter Micro-Macro Quantum Correlations, Phys. Rev. Lett. 116, 190502 (2016) Towards highly multimode optical quantum memory for quantum repeaters, Phys. Rev. A 93, 032327 (2016) Multiplexed on-demand storage of polarization qubits in a crystal, New Journal of Physics 18, 013006 (2016) Quantum memory for photons, Physics Today 68, 42-47 (2015) Coherent Spin Control at the Quantum Level in an Ensemble-Based Optical Memory, Phys. Rev. Lett. 114, 230502 (2015) Storage of hyperentanglement in a solid-state quantum memory, Optica 2, 279-287 (2015) A source of polarization-entangled photon pairs interfacing quantum memories with telecom photons, New Journal of Physics 16, 093058 (2014)
Communications Officer SIO Grafen and Graphene Centre
Responsible for the Communication activities for SIO Grafen, a strategic innovation program, funded by Vinnova, Energimyndigheten and Formas. It includes marketing and communicating on social media and web, arranging workshops and events.
Vice President, Systems Development
Mark Borodkin has a 20 year history of success in the development of systems for the life science and medical device industries. Prior to joining BioNano Genomics, Mark led a global team at Brooks Life Science Systems in the development of sample analyzers, high throughput screening solutions and chemical storage and biobank systems. Prior to Brooks, Mark was with Affymetrix where he launched the array platform that is widely used today for GWAS and other genomics applications. Mark also spent time at Siemens Healthcare Diagnostics on the development of equipment for diagnostic core labs. During his 13 years at Life Technologies (formerly Applied Biosystems) he held various levels of responsibility in the development of systems for Real Time PCR, sequencing and sample preparation. Mark holds a B.S. degree in Electrical Engineering and a M.S. degree in Computer and Systems Engineering from Rensselaer Polytechnic Institute in New York.
President and Chief Technology Officer
Dr. Oden L. Warren is the President and Chief Technology Officer at Hysitron, Inc. He received his Ph.D. in Physical Chemistry in 1993 from Iowa State University of Science & Technology, where he studied as an Amoco Foundation Fellow. His graduate research on surface crystallography of reconstructed thin films earned him an Alpha Chi Sigma Research Excellence Award. Thereafter, he conducted postdoctoral research at Sandia National Laboratories-New Mexico, and at The University of Western Ontario, in the area of interfacial force microscopy. After joining Hysitron in 1998, he led the development effort for the TriboIndenter® nanomechanical test instrument, the company's flagship product. In 2005, his concept of a three-dimensional nanomechanical tester received a Nano 50 Award from Nanotech Briefs for the physically realized 3D OmniProbe™ product. He is the Principal Investigator for Phase I (completed successfully in 2005) and Phase II (ongoing) SBIR grants awarded by the US Department of Energy for the development of quantitative nanoindentation in-situ to a transmission electron microscope. He also represents the company in drafting ASTM and ISO standards for instrumented indentation. He has been issued 11 US patents, given more than 30 invited talks, and has co-authored more than 70 papers, on nanomechanics, nanotribology, and surface science. Oden's papers have been cited over 2500 times with an h-index of 25. In 2015 Oden received Iowa State University's John V. Atanasoff Discovery Award, awarded to alumni who have significantly advanced scientific knowledge through laboratory accomplishments and/or management. His latest research interests include optimizing feedback-controlled nanoindentation, enhancing the role of nanoindentation in combinatorial materials science, and understanding fundamental deformation mechanisms through quantitative nanoindentation coupled to transmission electron microscopy. His technical expertise spans the range of nanomechanics, scanning probe microscopy, instrumentation and software development, capacitive transducer and piezoelectric actuator design, and ultra-high vacuum surface science.
Dr. Florian Libisch
Technische Universität Wien
Dr. Florian Libisch graduated from the Vienna University of Technology with a Ph.D. in theoretical physics in 2009. He was a postdoctoral researcher at Princeton University for two years and currently holds a faculty position in Vienna.
Donato M. Ceres
Advanced Diamond Technologies
Director of Innovation and System Development
Dr. Ceres has 15+ years of experiences in novel interdisciplinary technologies, such as nanotechnology, nanolithography, bio-electrochemistry, and biosensing. He has worked on the development of devices for the electrochemical diagnostics of DNA mutations, in-vivo diagnostics and drug screening, real-time electrochemical detection of biochemical processes in living cells, and for nanolithographic applications in the electronics and biomedical industry. Dr. Ceres managed products and projects for the development and commercialization of novel state-of-the-art nanotechnology products. Dr. Ceres has joined Advanced Diamond Technologies to bring and accelerate Diamonox® Technology to the water treatment markets by devising product development and business development strategies. Dr. Ceres received a MS degree in Physics from the Swiss Federal Institute of Technology (EPFL, Lausanne) and a Ph.D. in Chemistry from the California Institute of Technology (Caltech). He also received training in Project Management from the University of California Los Angeles (UCLA) as well as in Strategic Marketing of Technology Products from the Technology Marketing Center (Caltech Industrial Relations Center).